Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DME competitive bidding

This article was originally published in The Gray Sheet

Executive Summary

Diabetes product manufacturers favor administrative route over legislation to convince CMS that glucose monitors are sufficiently distinct from other durable medical equipment, prosthetics, orthotics and supplies to be omitted from products eligible for competitive bidding when the agency releases a notice of proposed rulemaking this summer. CMS' Program Oversight & Advisory Committee meets in Baltimore Feb. 28-March 2 to mull recommendations for implementing the program. Diabetes management firms also will work with Secretary of Veterans Affairs Jim Nicholson, sworn in Feb. 1, against procurement standardization of the products (1"The Gray Sheet" July 5, 2004, p. 3)...
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT021635

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel